分岐部病変の世界市場レポート 2024年

分岐部病変の市場規模は近年力強く成長しています。2023年の24億7,000万米ドルから2024年には27億米ドルへと、CAGR9.3％で成長します。分岐部病変の文脈で過去の期間に観察された成長は、いくつかの要因に起因しています。冠動脈疾患の有病率の上昇、高齢者人口の増加、医療支出の急増、全体的な経済成長などです。これらの要因は総体的に、指定された歴史的時間枠の間、分岐部病変に関連する介入と処置の拡大と発展に寄与しました。

分岐部病変市場で人気を集めている主要動向は、画像診断や処置に使用される機器の進歩です。同市場の主要企業は、画像診断や処置に使用される既存機器の強化に注力しています。例えば、臨床段階の医療機器企業であるAdvanced Bifurcation Systems（ABS）は、モジュール式自己整列ステント技術を特徴とする独自の分岐部ステント留置ソリューションを開発しました。このプラットフォームは、冠動脈形成術におけるすべての分岐部病変の治療を標準化することを目的としており、再手術の必要性を減らし、効果的な分岐部ステント治療を可能にする単一のシステムを提供します。分岐部病変市場の成長と革新に寄与しているのは、デバイスの進歩に向けた動向です。

2023年の分岐部病変市場で最大の地域は北米です。アジア太平洋は予測期間中に最も急成長する地域と予想されます。分岐部病変市場レポートの対象地域は、アジア太平洋、西欧、中東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 分岐部病変市場の特徴

第3章 分岐部病変市場の動向と戦略

第4章 分岐部病変市場-マクロ経済シナリオ

第5章 世界の分岐部病変市場規模と成長

• 世界の分岐部病変市場の促進要因と抑制要因
  • 市場の促進要因
  • 市場の抑制要因
• 世界の分岐部病変の市場規模実績と成長、2018～2023年
• 世界の分岐部病変の市場規模と成長予測、2023～2028年、2033年

第6章 分岐部病変市場セグメンテーション

• 世界の分岐部病変市場、タイプ別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• ワンステント
• ツーステント
• 世界の分岐部病変市場、用途別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 冠状血管
• 末梢血管

第7章 分岐部病変市場の地域と国分析

• 世界の分岐部病変市場、地域別、実績と予測、2018～2023年、2023～2028年、2033年
• 世界の分岐部病変市場、国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋の分岐部病変市場

第9章 中国の分岐部病変市場

第10章 インドの分岐部病変市場

第11章 日本の分岐部病変市場

第12章 オーストラリアの分岐部病変市場

第13章 インドネシアの分岐部病変市場

第14章 韓国の分岐部病変市場

第15章 西欧の分岐部病変市場

第16章 英国の分岐部病変市場

第17章 ドイツの分岐部病変市場

第18章 フランスの分岐部病変市場

第19章 イタリアの分岐部病変市場

第20章 スペインの分岐部病変市場

第21章 東欧の分岐部病変市場

第22章 ロシアの分岐部病変市場

第23章 北米の分岐部病変市場

第24章 米国の分岐部病変市場

第25章 カナダの分岐部病変市場

第26章 南米の分岐部病変市場

第27章 ブラジルの分岐部病変市場

第28章 中東の分岐部病変市場

第29章 アフリカの分岐部病変市場

第30章 分岐部病変市場の競合情勢と企業プロファイル

• 分岐部病変市場の競合情勢
• 分岐部病変市場の企業プロファイル
  • Boston Scientific Corporation
  • Terumo Medical Corporation
  • Spectranetics Corporation
  • Medtronic plc
  • Cardinal Health Inc.

第31章 世界の分岐部病変市場の競合ベンチマーキング

第32章 世界の分岐部病変市場の競合ダッシュボード

第33章 分岐部病変市場における主要な合併と買収

第34章 分岐部病変市場の将来展望と可能性分析

第35章 付録

“Bifurcation Lesions Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bifurcation lesions market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bifurcation lesions? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The bifurcation lesions market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Types: One-Stent; Two-Stent
• 2) By Application: Coronary Vascular; Peripheral Vascular
• Companies Mentioned: Boston Scientific Corporation; Terumo Medical Corporation; Spectranetics Corporation; Medtronic plc; Cardinal Health Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Bifurcation lesions in the context of coronary arteries refer to constrictions that occur adjacent to or involve the origin of a critical side branch that one aims to preserve. This situation arises when there is an accumulation of plaque deposits, causing the artery to become too narrow, thereby hindering adequate blood flow to the heart.

The main categorizations of bifurcation lesions are one-stent and two-stent approaches. In a one-stent bifurcation lesion procedure, the side branch is provisionally stented if intervention is deemed necessary based on clinical complaints, angiographic results, or other relevant factors. In this approach, the main branch is stented first. The bifurcation angle is determined by the internal angle between the main and side branches. These types of bifurcation lesions are encountered in both coronary and peripheral vascular contexts.

The bifurcation lesions market research report is one of a series of new reports from The Business Research Company that provides bifurcation lesions market statistics, including bifurcation lesions industry global market size, regional shares, competitors with a bifurcation lesions market share, detailed bifurcation lesions market segments, market trends and opportunities, and any further data you may need to thrive in the bifurcation lesions industry. This bifurcation lesions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The bifurcation lesions market size has grown strongly in recent years. It will grow from $2.47 billion in 2023 to $2.7 billion in 2024 at a compound annual growth rate (CAGR) of 9.3%. The growth observed during the historical period in the context of bifurcation lesions can be attributed to several factors. These include the rise in the prevalence of coronary artery diseases, an increase in the geriatric population, a surge in healthcare expenditure, and overall economic growth. These factors collectively contributed to the expansion and development of interventions and procedures related to bifurcation lesions during the specified historical timeframe.

The bifurcation lesions market size is expected to see strong growth in the next few years. It will grow to $3.74 billion in 2028 at a compound annual growth rate (CAGR) of 8.5%. The anticipated growth in the forecast period for interventions related to bifurcation lesions can be attributed to various factors. These include the increasing demand for minimally invasive surgeries, the expansion of healthcare infrastructure and facilities, a rising prevalence of cardiovascular diseases, and supportive government healthcare policies. Major trends expected during this period include the adoption of patient-centric approaches, the development of bioresorbable stents, the integration of artificial intelligence (AI) and machine learning in treatment approaches, and increased cross-specialty collaboration. These trends highlight significant considerations in the healthcare landscape as it evolves to meet the demands of patients and leverage advancements in medical technology.

The growth of the bifurcation lesions market is expected to be driven by the increasing geriatric population. Individuals aged 60 and above are more susceptible to heart-related issues such as heart attacks, strokes, coronary heart disease, and heart failure. Bifurcation lesions play a crucial role in treating blood clots and facilitating adequate blood flow to the heart in such cases. A report by the World Health Organization (WHO) projected that by 2030, one in six people globally would be 60 or older, and by 2050, the number of individuals aged 80 and above would increase by 426 million compared to the current population. The rise in the geriatric population is anticipated to be a significant driver for the bifurcation lesions market.

The growth of the bifurcation lesions market is further expected to be boosted by increasing healthcare expenditure. Higher healthcare spending enables healthcare facilities to invest in advanced interventional cardiology devices, including those used for treating bifurcation lesions. According to the 2021-2030 National Health Expenditure (NHE) report by the Centers for Medicare & Medicaid Services, national health spending is estimated to increase by an average of 5.1% annually, reaching nearly $6.8 trillion between 2021 and 2030. The report also anticipates an annual increase of 7.2% in Medicare spending and 5.6% in Medicaid spending during the same period. The upward trend in healthcare expenditure is a significant driver for the bifurcation lesions market.

A key trend gaining popularity in the bifurcation lesions market is the advancement in devices used in imaging and procedures. Leading companies in the market are focusing on enhancing existing devices used in imaging and procedures. For example, Advanced Bifurcation Systems (ABS), a clinical-stage medical device firm, has developed a unique bifurcation stenting solution featuring modular self-aligning stent technology. This platform aims to standardize the treatment of all bifurcation lesions in coronary angioplasties, providing a single system that reduces the need for repeat procedures and enables effective bifurcation stenting treatment. The trend towards device advancement is contributing to the growth and innovation in the bifurcation lesions market.

Leading companies in the bifurcation lesions market are actively developing innovative products such as drug-eluting coronary stent systems to expand their customer base, increase sales, and drive revenue growth. A drug-eluting coronary stent system is a specialized medical device used in interventional cardiology for the treatment of coronary artery disease. In August 2023, Medtronic PLC, an Ireland-based medical device company, introduced the Onyx Frontier drug-eluting stent (DES) to address non-left main bifurcation lesions using the provisional stenting technique. This product incorporates several design enhancements, including a dual-layer balloon, reduced crossing profile, and enhanced catheter flexibility. The improvements result in a 16% enhancement in deliverability compared to the prior-generation Resolute Onyx DES, maintaining the same level of radial strength. Onyx Frontier offers an extensive range of sizes, accommodating patient needs with diameters ranging from 2.0mm to 5.0mm, with specific sizing for the treatment of extra-large vessels, including those in the left main. The product inherits clinical data and indications from Resolute Onyx, including approval for treating bifurcation lesions, left main percutaneous coronary intervention (PCI), and a recommended one-month duration of dual antiplatelet therapy (DAPT) for high bleeding risk patients.

In September 2021, Boston Scientific Corporation, a US-based biomedical engineering firm, acquired Devoro Medical, Inc. to focus on clot management and commercialization utilizing the WOLF Thrombectomy Platform developed by Devoro Medical. The innovative WOLF technology uses finger-like prongs to extract and remove thrombi in the arterial and venous systems swiftly. This acquisition enhances Boston Scientific's range of interventional strategies for thromboemboli, including the AngioJet Thrombectomy System and the EkoSonic Endovascular System (EKOS). Devoro Medical, Inc., a US-based company, is a developer of a medical device designed to restore blood flow.

Major companies operating in the bifurcation lesions market include Boston Scientific Corporation, Terumo Medical Corporation, Spectranetics Corporation, Medtronic PLC, Cardinal Health Inc., Cardinal Health Company, Abbott Laboratories, Biosensors International Group Ltd., B. Braun Melsungen AG, Cook Medical LLC, Cordis Corporation, Endologix Inc., W. L. Gore & Associates Inc., InspireMD Inc., Lombard Medical Technologies PLC, MicroPort Scientific Corporation, OrbusNeich Medical Company Limited, Biotronik SE & Co. KG, Cardionovum GmbH, Elixir Medical Corporation, Medinol Ltd., Meril Life Sciences Pvt. Ltd., MIV Therapeutics Inc., Natec Medical Ltd., Opto Circuits (India) Ltd., QualiMed Innovative Medizinprodukte GmbH, Sahajanand Medical Technologies Pvt. Ltd., Svelte Medical Systems Inc., Translumina GmbH, Vascular Concepts Limited, Vascular Solutions Inc., Veryan Medical Ltd., X-Cell Medical Inc., Zorion Medical Inc., Amaranth Medical Inc., Cardiomind Inc., Cardiva Medical Inc.

North America was the largest region in the bifurcation lesions market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in bifurcation lesions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the bifurcation lesions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The bifurcation lesions market includes revenues earned by proximal main branch (MB), distal MB and side branch (SB). The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Bifurcation Lesions Market Characteristics

3. Bifurcation Lesions Market Trends And Strategies

4. Bifurcation Lesions Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Bifurcation Lesions Market Size and Growth

• 5.1. Global Bifurcation Lesions Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Bifurcation Lesions Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Bifurcation Lesions Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Bifurcation Lesions Market Segmentation

• 6.1. Global Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• One-Stent
• Two-Stent
• 6.2. Global Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Coronary Vascular
• Peripheral Vascular

7. Bifurcation Lesions Market Regional And Country Analysis

• 7.1. Global Bifurcation Lesions Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Bifurcation Lesions Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Bifurcation Lesions Market

• 8.1. Asia-Pacific Bifurcation Lesions Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Bifurcation Lesions Market

• 9.1. China Bifurcation Lesions Market Overview
• 9.2. China Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Bifurcation Lesions Market

• 10.1. India Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Bifurcation Lesions Market

• 11.1. Japan Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.2. Japan Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Bifurcation Lesions Market

• 12.1. Australia Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Bifurcation Lesions Market

• 13.1. Indonesia Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Bifurcation Lesions Market

• 14.1. South Korea Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.2. South Korea Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Bifurcation Lesions Market

• 15.1. Western Europe Bifurcation Lesions Market Overview
• 15.2. Western Europe Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Bifurcation Lesions Market

• 16.1. UK Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Bifurcation Lesions Market

• 17.1. Germany Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Bifurcation Lesions Market

• 18.4. France Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.5. France Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Bifurcation Lesions Market

• 19.7. Italy Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.8. Italy Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Bifurcation Lesions Market

• 20.10. Spain Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.11. Spain Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Bifurcation Lesions Market

• 21.1. Eastern Europe Bifurcation Lesions Market Overview
• 21.2. Eastern Europe Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Bifurcation Lesions Market

• 22.1. Russia Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Bifurcation Lesions Market

• 23.1. North America Bifurcation Lesions Market Overview
• 23.2. North America Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Bifurcation Lesions Market

• 24.1. USA Bifurcation Lesions Market Overview
• 24.2. USA Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Bifurcation Lesions Market

• 25.1. Canada Bifurcation Lesions Market Overview
• 25.2. Canada Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Bifurcation Lesions Market

• 26.1. South America Bifurcation Lesions Market Overview
• 26.2. South America Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Bifurcation Lesions Market

• 27.1. Brazil Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Bifurcation Lesions Market

• 28.1. Middle East Bifurcation Lesions Market Overview
• 28.2. Middle East Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Bifurcation Lesions Market

• 29.1. Africa Bifurcation Lesions Market Overview
• 29.2. Africa Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Bifurcation Lesions Market, Segmentation BY Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Bifurcation Lesions Market Competitive Landscape And Company Profiles

• 30.1. Bifurcation Lesions Market Competitive Landscape
• 30.2. Bifurcation Lesions Market Company Profiles
  • 30.2.1. Boston Scientific Corporation
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Terumo Medical Corporation
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Spectranetics Corporation
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Medtronic plc
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Cardinal Health Inc.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global Bifurcation Lesions Market Competitive Benchmarking

32. Global Bifurcation Lesions Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Bifurcation Lesions Market

34. Bifurcation Lesions Market Future Outlook and Potential Analysis

• 34.1 Bifurcation Lesions Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Bifurcation Lesions Market In 2028 - Segments Offering Most New Opportunities
• 34.3 Bifurcation Lesions Market In 2028 - Growth Strategies
• 34.3.1 Market Trend Based Strategies
• 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer